Key facts
- WellTheory’s last known valuation is $69.0M (Oct 2025).
- It has raised $45.3M; the latest was Later Stage VC ($19.1M) in Feb 2026.
- Notable investors include General Catalyst, Accel, BoxGroup, Samsung NEXT Ventures, Lux Capital — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for WellTheory
- ·The full record, as it builds
Funding rounds
No funding rounds for WellTheory are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About WellTheory
Operator of a virtual care platform intended to support clients in their immunological journey. The company's tool combines community care, dietary, and lifestyle changes to offer personalized insights and evidence-based recommendations into a membership experience, enabling individuals with the proper care to reverse the autoimmune epidemic.
- Sector
- Healthcare
- HQ
- Atherton, CA, United States
- Founded
- 2020
- Employees
- 42
- Website
- welltheory.com/
- Ownership
- Privately Held (backing)
WellTheory doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in WellTheory shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on WellTheory in its N-PORT filings yet. We sweep new filings monthly.